Cargando…
Tumour suppressor TRIM33 targets nuclear β-catenin degradation
Aberrant activation of β-catenin in the nucleus has been implicated in a variety of human cancers but the fate of nuclear β-catenin is unknown. Here we demonstrate that tripartite motif-containing protein 33 (TRIM33), acting as an E3 ubiquitin ligase, reduces the abundance of nuclear β-catenin prote...
Autores principales: | Xue, Jianfei, Chen, Yaohui, Wu, Yamei, Wang, Zhongyong, Zhou, Aidong, Zhang, Sicong, Lin, Kangyu, Aldape, Kenneth, Majumder, Sadhan, Lu, Zhimin, Huang, Suyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315364/ https://www.ncbi.nlm.nih.gov/pubmed/25639486 http://dx.doi.org/10.1038/ncomms7156 |
Ejemplares similares
-
Nuclear GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing its deubiquitination by USP22
por: Zhou, Aidong, et al.
Publicado: (2016) -
TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role
por: Caratozzolo, Mariano Francesco, et al.
Publicado: (2017) -
Cellular TRIM33 restrains HIV-1 infection by targeting viral integrase for proteasomal degradation
por: Ali, Hashim, et al.
Publicado: (2019) -
Identification
of Histone Peptide Binding Specificity
and Small-Molecule Ligands for the TRIM33α and TRIM33β
Bromodomains
por: Sekirnik, Angelina R., et al.
Publicado: (2022) -
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours
por: Mastropasqua, Francesca, et al.
Publicado: (2017)